iecs.org.ar

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis

I. D. Gallos,A. Papadopoulou,R. Man,N. Athanasopoulos,A. Tobias,M. J. Price,M. J. Williams,V. Diaz,J. Pasquale,M. Chamillard,M. Widmer,Ö. Tunçalp,G. J. Hofmeyr,F. Althabe,A. M. Gülmezoglu,J. P. Vogel,O. T. Oladapo and A. Coomarasamy. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12(12):10.1002/14651858.CD011689.pub3.

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis Ver más »

Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis

W. R. Parry Smith,A. Papadopoulou,E. Thomas,A. Tobias,M. J. Price,S. Meher,Z. Alfirevic,A. D. Weeks,G. J. Hofmeyr,A. M. Gülmezoglu,M. Widmer,O. T. Oladapo,J. P. Vogel,F. Althabe,A. Coomarasamy and I. D. Gallos. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11(11):10.1002/14651858.CD012754.pub2.

Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis Ver más »

Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity

J. Alger,M. L. Cafferata,T. Alvarado,A. Ciganda,A. Corrales,H. Desale,A. Drouin,D. Fusco,J. Garcia,L. Gibbons,E. Harville,W. Lopez,I. Lorenzana,F. Muñoz-Lara,E. Palou,E. Retes,M. Sierra,C. Stella,X. Xiong,L. I. Zambrano and P. Buekens. Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity. Matern Child Health J. 2020;24(9):10.1007/s10995-020-02981-9.

Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity Ver más »

Uses and Applications of Eq-5d in Latin America & the Caribbean: Systematic Review and Bibliometric Analysis

L. Rey-Ares,A. Hernandez-Vasquez,V. Irazola,D. Comande and F. Augustovski. USES AND APPLICATIONS OF EQ-5D IN LATIN AMERICA & THE CARIBBEAN: SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS. Value in Health. 2017;20(9):10.1016/j.jval.2017.08.2801.

Uses and Applications of Eq-5d in Latin America & the Caribbean: Systematic Review and Bibliometric Analysis Ver más »

Use of oral health care services in Peru: trends of socio-economic inequalities before and after the implementation of Universal Health Assurance

A. Hernández-Vásquez,G. Bendezu-Quispe,D. Azañedo and M. Santero. Use of oral health care services in Peru: trends of socio-economic inequalities before and after the implementation of Universal Health Assurance. BMC Oral Health. 2019;19(1):10.1186/s12903-019-0731-7.

Use of oral health care services in Peru: trends of socio-economic inequalities before and after the implementation of Universal Health Assurance Ver más »

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area

F. Cicora,V. Escurra,S. Silguero,I. M. González and J. E. Roberti. Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area. Transplantation. 2014;97(1):10.1097/01.Tp.0000437673.86339.82.

Use of kidneys from trypanosoma cruzi-infected donors in naive transplant recipients without prophylactic therapy: the experience in a high-risk area Ver más »

Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience

F. Cicora,M. Paz,F. Mos and J. Roberti. Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience. Transpl Immunol. 2013;29(1-4):10.1016/j.trim.2013.08.003.

Use of bortezomib to treat anti-HLA antibodies in renal transplant patients: a single-center experience Ver más »

Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy

F. Cicora,M. Paz,F. Mos and J. Roberti. Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy. Case Rep Med. 2013;2013:10.1155/2013/260254.

Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy Ver más »

Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries

M. Berrueta,J. Hemingway-Foday,V. R. Thorsten,R. L. Goldenberg,W. A. Carlo,A. Garces,A. Patel,S. Saleem,O. Pasha,E. Chomba,P. L. Hibberd,N. F. Krebs,S. Goudar,R. J. Derman,F. Esamai,E. A. Liechty,J. L. Moore,E. M. McClure,M. Koso-Thomas,P. M. Buekens,J. M. Belizán and F. Althabe. Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries. Reprod Health. 2016;13(1):10.1186/s12978-016-0176-2.2016

Use of antenatal corticosteroids at health facilities and communities in low-and-middle income countries Ver más »

Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina

M. V. Salgado,P. Coxson,J. Konfino,J. Penko,V. E. Irazola,L. Gutiérrez,A. Fernández and R. Mejía. Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina. Medicina (B Aires). 2019;79(6).

Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina Ver más »